Prism Research, LLC

Description

Charles E. Halstenson, Pharm. D., CEO Chuck Halstenson is a research and healthcare executive with over 30 years of diverse management and entrepreneurial experience including clinical research and multi-site healthcare systems. Chuck received his Pharm. D. degree from the University of Minnesota. He co-directed operations for a phase I unit for over 17 years. Chuck is a Clinical Professor, Department of Pharmacy Practice at the College of Pharmacy, University of Minnesota.

Jeffrey D. Cosgrove, President Jeff Cosgrove is a research executive with over 20 years of experience in operational management of clinical research for the pharmaceutical industry. Jeff's previous experience includes creating and managing recruitment for a phase I organization and directing operations for phase I trials. Jeff has been published in industry publications, served as a guest faculty lecturer for the University of Minnesota, Masters in Research Program as well numerous other associations.

IND 2 Results (I2R) is a full service CRO that supports smaller biopharma companies working in complex therapeutic areas. We have a global network of associates, each with more than 20 years' experience in leading the clinical development and clinical trial process. Our services include everything from an initial IND submission to clinical trial planning and execution, through analysis and study report. Our approach is to partner with our clients to create consultative and collaborative working relationships that impact current results and planning for future studies.

It is our goal to provide a comfortable experience for our most important asset: our volunteers. Our clean, comfortable and modern facility is designed to meet the needs of our volunteers with access to semi-private and common areas accommodating a variety of activities.

Fact sheet

Products & services

Similar companies nearby